Fulltext

Gamma-tocotrienol treatment increased peroxiredoxin-4 expression in HepG2 liver cancer cell line

Abdul Rahman Sazli F 1 , Jubri Z 2 , Abdul Rahman M 3 , Karsani SA 4 , Md Top AG 5 , Wan Ngah WZ 6

Affiliations 

  • 1 Department of Biochemistry, Universiti Kebangsaan Malaysia Medical Centre, Kuala Lumpur, Malaysia. farahsazli@gmail.com
  • 2 Department of Biochemistry, Universiti Kebangsaan Malaysia Medical Centre, Kuala Lumpur, Malaysia. zakiah@medic.ukm.my
  • 3 Department of Clinical Oral Biology, Faculty of Dentistry, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia. mariati_ar@dental.ukm.my
  • 4 Institute of Biological Sciences, Faculty of Science, University of Malaya and University of Malaya Centre for Proteomics Research (UMCPR), Kuala Lumpur, Malaysia. saiful72@um.edu.my
  • 5 Malaysian Palm Oil Board, Bangi, Selangor, Malaysia. gapor@mpob.gov.my
  • 6 Department of Biochemistry, Universiti Kebangsaan Malaysia Medical Centre, Kuala Lumpur, Malaysia. zurina@medic.ukm.my
BMC Complement Altern Med, 2015;15:64.
PMID: 25886747 DOI: 10.1186/s12906-015-0590-y

Abstract

To determine the antiproliferative effect of gamma-tocotrienol (GTT) treatment on differential protein expression in HepG2 cells.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications